MOS (or CSF) is a mitogen-activated protein kinase kinase kinase (MAP3K) that is present in eggs during meiosis. It is destroyed after exit from meiosis II before fertilisation. It provides a good marker for studies of oocytes during oogenesis and maturation.
| Inventor | Institute |
|---|---|
| Julian Gannon | Cancer Research UK, London Research Institute: Clare Hall Laboratories |
| SKU: | 151019 |
|---|---|
| Product description: | MOS (or CSF) is a mitogen-activated protein kinase kinase kinase (MAP3K) that is present in eggs during meiosis. It is destroyed after exit from meiosis II before fertilisation. It provides a good marker for studies of oocytes during oogenesis and maturation. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Immunogen: | Recombinant (Xenopus laevis) Mos fusion protein |
| Myeloma used: | Sp2/0-Ag14 |
| Cat. #: | 151019 |
|---|---|
| Provenance and Ownership: | The Anti-Mos [S3.1] is owned by Cancer Research UK. CancerTools supplies the Anti-Mos [S3.1] under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-Mos [S3.1] directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer; Cell biology; Cell signaling and signal transduction; Developmental biology; Genetics; Stem cell biology |
| Application: | IHC ; IP ; WB |
| Target: | Mos |
| Reactivity: | Xenopus laevis |
| Clone: | S3.1 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | MOS (or CSF) is a mitogen-activated protein kinase kinase kinase (MAP3K) that is present in eggs during meiosis. It is destroyed after exit from meiosis II before fertilisation. It provides a good marker for studies of oocytes during oogenesis and maturation. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | ‘-15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Personal communication. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.